Meerecompany is a pioneering enterprise in the medical robot market, having successfully commercialized 'Revo-i', Korea's first laparoscopic surgical robot. It is also a global innovation company, providing advanced technological solutions across various industrial sectors through the development of display and semiconductor manufacturing equipment and 3D sensor modules.Meerecompanyisapioneeringenterpriseinthemedicalrobotmarket,havingsuccessfullycommercialized'Revo-i',Korea'sfirstlaparoscopicsurgicalrobot.Itisalsoaglobalinnovationcompany,providingadvancedtechnologicalsolutionsacrossvariousindustrialsectorsthroughthedevelopmentofdisplayandsemiconductormanufacturingequipmentand3Dsensormodules.
Key Products/TechnologiesKeyProducts/Technologies
The 'Revo-i' surgical robot is a laparoscopic surgical system offering high-resolution 3D stereoscopic images and a wide field of view. A product characterized by precise movements through multi-joint instruments and intuitive control functions. Development and supply of 'Revo-Sim', a VR-based training simulator for enhancing medical professionals' proficiency. Revo-Sim includes training modes for basic operations, suturing and anastomosis, and advanced procedures such as hysterectomy, nephrectomy, and cholecystectomy. In the industrial equipment sector, the company produces 'Edge Grinder' for precision polishing of display panel edges, glass substrate edge inspection equipment, and laser trimmers, markers, and cutters. In the semiconductor field, it successfully commercialized wafer surface polishing equipment specialized for FO-WLP and Glass Carrier-based packaging processes, a world first. Possessing Time-of-Flight (ToF) 3D sensor module technology, utilized in various application areas.The'Revo-i'surgicalrobotisalaparoscopicsurgicalsystemofferinghigh-resolution3Dstereoscopicimagesandawidefieldofview.Aproductcharacterizedbyprecisemovementsthroughmulti-jointinstrumentsandintuitivecontrolfunctions.Developmentandsupplyof'Revo-Sim',aVR-basedtrainingsimulatorforenhancingmedicalprofessionals'proficiency.Revo-Simincludestrainingmodesforbasicoperations,suturingandanastomosis,andadvancedproceduressuchashysterectomy,nephrectomy,andcholecystectomy.Intheindustrialequipmentsector,thecompanyproduces'EdgeGrinder'forprecisionpolishingofdisplaypaneledges,glasssubstrateedgeinspectionequipment,andlasertrimmers,markers,andcutters.Inthesemiconductorfield,itsuccessfullycommercializedwafersurfacepolishingequipmentspecializedforFO-WLPandGlassCarrier-basedpackagingprocesses,aworldfirst.PossessingTime-of-Flight(ToF)3Dsensormoduletechnology,utilizedinvariousapplicationareas.
Core AdvantagesCoreAdvantages
The successful commercialization of 'Revo-i', Korea's first laparoscopic surgical robot, establishes a key competitive advantage in leading domestic medical robot technology. The successful localization of display edge grinders and maintaining the world's number one market share for 21 years demonstrates unique technological prowess. The world's first commercialization of wafer surface polishing equipment for semiconductor Glass Carrier-based packaging and the absence of competing equipment secure a dominant position in the market. Offering high-performance surgical robots at a reasonable price compared to international competitors provides a strong price competitiveness. A diversified business portfolio, continuously reinvesting stable profits from display and semiconductor equipment businesses into new ventures like surgical robots and sensors. A high proportion of R&D expenditure and over 50% of the workforce dedicated to research personnel form the foundation of its technological innovation capabilities. Possession of over 259 patents in 6 countries including Korea, China, and the USA, representing a strong intellectual property portfolio.Thesuccessfulcommercializationof'Revo-i',Korea'sfirstlaparoscopicsurgicalrobot,establishesakeycompetitiveadvantageinleadingdomesticmedicalrobottechnology.Thesuccessfullocalizationofdisplayedgegrindersandmaintainingtheworld'snumberonemarketsharefor21yearsdemonstratesuniquetechnologicalprowess.Theworld'sfirstcommercializationofwafersurfacepolishingequipmentforsemiconductorGlassCarrier-basedpackagingandtheabsenceofcompetingequipmentsecureadominantpositioninthemarket.Offeringhigh-performancesurgicalrobotsatareasonablepricecomparedtointernationalcompetitorsprovidesastrongpricecompetitiveness.Adiversifiedbusinessportfolio,continuouslyreinvestingstableprofitsfromdisplayandsemiconductorequipmentbusinessesintonewventureslikesurgicalrobotsandsensors.AhighproportionofR&Dexpenditureandover50%oftheworkforcededicatedtoresearchpersonnelformthefoundationofitstechnologicalinnovationcapabilities.Possessionofover259patentsin6countriesincludingKorea,China,andtheUSA,representingastrongintellectualpropertyportfolio.
Target IndustriesTargetIndustries
In the medical industry, the 'Revo-i' laparoscopic surgical robot is utilized in various minimally invasive surgeries in urology, general surgery, and obstetrics and gynecology. Specifically applied in complex procedures such as high-difficulty bile duct surgery, gastric cancer, uterine fibroid, and ovarian cyst resections. In the display industry, the company supplies essential equipment for panel manufacturing processes, including edge grinders, inspection equipment, and laser application devices. In the semiconductor industry, it provides critical equipment for semiconductor manufacturing processes, such as wafer edge grinders, bare wafer grinders, and wafer surface polishing equipment for next-generation high-density packaging processes. 3D sensor modules are applied in a wide range of industrial sectors, including consumer electronics, automotive, security and surveillance, augmented reality (AR), virtual reality (VR), 3D scanning and mapping, and robotics.Inthemedicalindustry,the'Revo-i'laparoscopicsurgicalrobotisutilizedinvariousminimallyinvasivesurgeriesinurology,generalsurgery,andobstetricsandgynecology.Specificallyappliedincomplexproceduressuchashigh-difficultybileductsurgery,gastriccancer,uterinefibroid,andovariancystresections.Inthedisplayindustry,thecompanysuppliesessentialequipmentforpanelmanufacturingprocesses,includingedgegrinders,inspectionequipment,andlaserapplicationdevices.Inthesemiconductorindustry,itprovidescriticalequipmentforsemiconductormanufacturingprocesses,suchaswaferedgegrinders,barewafergrinders,andwafersurfacepolishingequipmentfornext-generationhigh-densitypackagingprocesses.3Dsensormodulesareappliedinawiderangeofindustrialsectors,includingconsumerelectronics,automotive,securityandsurveillance,augmentedreality(AR),virtualreality(VR),3Dscanningandmapping,androbotics.
The 'Revo-i' laparoscopic surgical robot secured domestic Ministry of Food and Drug Safety (MFDS) manufacturing approval and CE certification in 2017. It was officially recognized for its technology and safety, designated as Innovative Medical Device No. 10 in 2021. The company holds numerous certifications, including being selected as a venture company in 1998, acquiring the Korean New Technology (KT) mark in 1999, and its Edge Grinder being designated as a World-Class Product in 2005. It earned accolades such as being selected as a World Class 300 company in 2016, receiving the Best Techno Company Award at the KOSDAQ Awards in 2017, and winning the Grand Prize at the Korea KOSDAQ Awards in 2018. Further recognition includes selection as a 'Materials, Parts, and Equipment (SoBuJang) Leading Company' and 'National Representative 1000 Innovative Companies' in 2021. Its technological prowess received external validation, being named 'Korea Robot Company of the Year' by Robot Newspaper in 2021. A significant achievement was the JMIS Excellent Paper Award at the 2026 Spring Conference of the Korean Society of Endoscopic & Robotic Surgeons for clinical outcomes of high-difficulty bile duct surgery using 'Revo-i'. The company possesses a robust intellectual property portfolio with over 259 patents in 6 countries including Korea, China, and the USA, comprising 260 active patents and 167 international patents as of 2022.The'Revo-i'laparoscopicsurgicalrobotsecureddomesticMinistryofFoodandDrugSafety(MFDS)manufacturingapprovalandCEcertificationin2017.Itwasofficiallyrecognizedforitstechnologyandsafety,designatedasInnovativeMedicalDeviceNo.10in2021.Thecompanyholdsnumerouscertifications,includingbeingselectedasaventurecompanyin1998,acquiringtheKoreanNewTechnology(KT)markin1999,anditsEdgeGrinderbeingdesignatedasaWorld-ClassProductin2005.ItearnedaccoladessuchasbeingselectedasaWorldClass300companyin2016,receivingtheBestTechnoCompanyAwardattheKOSDAQAwardsin2017,andwinningtheGrandPrizeattheKoreaKOSDAQAwardsin2018.Furtherrecognitionincludesselectionasa'Materials,Parts,andEquipment(SoBuJang)LeadingCompany'and'NationalRepresentative1000InnovativeCompanies'in2021.Itstechnologicalprowessreceivedexternalvalidation,beingnamed'KoreaRobotCompanyoftheYear'byRobotNewspaperin2021.AsignificantachievementwastheJMISExcellentPaperAwardatthe2026SpringConferenceoftheKoreanSocietyofEndoscopic&RoboticSurgeonsforclinicaloutcomesofhigh-difficultybileductsurgeryusing'Revo-i'.Thecompanypossessesarobustintellectualpropertyportfoliowithover259patentsin6countriesincludingKorea,China,andtheUSA,comprising260activepatentsand167internationalpatentsasof2022.
Introduction
Location
69-12 Jeongmunsongsan-ro, Yanggam-myeon, Hwaseong-si, Gyeonggi-do, South Korea
클릭하여 위치 살펴보기
Information
69-12 Jeongmunsongsan-ro, Yanggam-myeon, Hwaseong-si, Gyeonggi-do, South Korea